Client preferences for the design and delivery of injectable opioid agonist treatment services: Results from a best-worst scaling task.

Rebecca Kathleen MetcalfeSophia DobischokNick BansbackScott MacDonaldDavid ByresJulie LajeunesseScott HarrisonBryce KochBlue ToppingTerry BrockJulie ForemanMartin SchechterEugenia Oviedo-Joekes

Published in: Addiction (Abingdon, England) (2024)

Injectable opioid agonist treatment (iOAT) clients surveyed in Vancouver, Canada, appear to prefer greater autonomy than they currently have in choosing OAT medication type, dosage and treatment schedule.

Keyphrases

healthcare
chronic pain
primary care
emergency department
hepatitis c virus
electronic health record
men who have sex with men